Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
108,074,661
-
Total 13F shares
-
29,070,550
-
Share change
-
-6,535,370
-
Total reported value
-
$31,395,961
-
Price per share
-
$1.08
-
Number of holders
-
76
-
Value change
-
-$19,214,772
-
Number of buys
-
32
-
Number of sells
-
45
Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock (ACRS) as of Q3 2019
As of 30 Sep 2019,
Aclaris Therapeutics, Inc. - Common Stock (ACRS) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,070,550 shares.
The largest 10 holders included
Man Group plc, BlackRock Inc., Rock Springs Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, Sofinnova Investments, Inc., Endurant Capital Management LP, MORGAN STANLEY, Broadfin Capital, LLC, MFN Partners Management, LP, and VANGUARD GROUP INC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.